The present study focuses on the development and the in vitro evaluation of a radiolabeled MNT possessing epidermal growth factor (EGF) as the ligand module, which ultimately might be suitable for targeting the many types of cancers overexpressing EGF receptors (EGFR) [8]. The gene discussed is EGF; the disease is cancer.